Literature DB >> 10383948

Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor.

K Sugie1, T Tomura, K Takakura, T Kawano, M Taniguchi, H M Grey, K Ishizaka.   

Abstract

Receptors for bioactive glycosylation-inhibiting factor (GIF) were demonstrated using a bioactive mutant of recombinant human (rh) GIF, which is comparable to the suppressor T (Ts) cell-derived bioactive GIF in its affinity for the receptors on helper T (Th) hybridoma cells. Both naive T and B cells in normal mouse spleen lacked GIF receptors. However, presentation of specific antigen to naive T cells resulted in the expression of the receptors on activated T cells. Furthermore, activation of small resting B cells with F(ab')2 fragments of anti-mouse IgM plus IL-4, lipopolysaccharide (LPS) plus IL-4 or LPS plus dextran sulfate induced the expression of the receptors within 48 h of B cell stimulation. It was also found that NK T cells freshly isolated from mouse spleen, but not conventional NK cells, expressed receptors for GIF. CD4(+) and CD4(-) subpopulations of NK T cells showed a similar binding capability. Mature dendritic cells derived from bone marrow did not bear the receptors. The dissociation constant (Kd) of the interaction between the bioactive rhGIF mutant and the high-affinity receptors was 10-100 pM, whereas inactive wild-type rhGIF failed to bind to the receptors. A bioactive derivative of rhGIF suppressed both IgG1 and IgE synthesis by purified B cells activated by LPS and IL-4, indicating that the binding of bioactive GIF to its receptors on activated B cells results in suppression of their differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383948     DOI: 10.1093/intimm/11.7.1149

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  5 in total

1.  Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.

Authors:  H Watarai; R Nozawa; A Tokunaga; N Yuyama; M Tomas; A Hinohara; K Ishizaka; Y Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.

Authors:  Laura M Elsby; Rachelle Donn; Zaynab Alourfi; Laura M Green; Elaine Beaulieu; David W Ray
Journal:  Arthritis Rheum       Date:  2009-08

3.  CD4 cell-secreted, posttranslationally modified cytokine GIF suppresses Th2 responses by inhibiting the initiation of IL-4 production.

Authors:  Misa Kim-Saijo; Edith M Janssen; Katsuji Sugie
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

Review 4.  Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning.

Authors:  Lisa Schindler; Nina Dickerhof; Mark B Hampton; Jürgen Bernhagen
Journal:  Redox Biol       Date:  2017-12-06       Impact factor: 11.799

5.  Xenografting of human umbilical mesenchymal stem cells from Wharton's jelly ameliorates mouse spinocerebellar ataxia type 1.

Authors:  Pei-Jiun Tsai; Chang-Ching Yeh; Wan-Jhen Huang; Ming-Yuan Min; Tzu-Hao Huang; Tsui-Ling Ko; Pei-Yu Huang; Tien-Hua Chen; Sanford P C Hsu; Bing-Wen Soong; Yu-Show Fu
Journal:  Transl Neurodegener       Date:  2019-09-05       Impact factor: 8.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.